{"name": "Reata Pharmaceuticals",
 "permalink": "reata-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/reata-pharmaceuticals",
 "homepage_url": "http://www.reatapharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@reatapharma.com",
 "phone_number": "972-865-2219",
 "description": "",
 "created_at": "Tue Jul 13 01:48:18 UTC 2010",
 "updated_at": "Wed Feb 22 20:23:02 UTC 2012",
 "overview": "\u003Cp\u003EReata Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant inflammation modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal/cardiovascular and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. The company was founded in 2002 and is based in Irving, Texas.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[101,
       74],
      "assets/images/resized/0009/3101/93101v2-max-150x150.png"],
     [[101,
       74],
      "assets/images/resized/0009/3101/93101v2-max-250x250.png"],
     [[101,
       74],
      "assets/images/resized/0009/3101/93101v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Warren",
      "last_name": "Huff",
      "permalink": "warren-huff",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$78M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.reatapharma.com/news_detail.asp?id=62",
    "source_description": "Reata Pharmaceuticals Completes $78 Million Equity Financing for Second Pivotal Trial of Bardoxolone Methy",
    "raised_amount": 78000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "CPMG",
         "permalink": "cpmg",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2801 Gateway Drive",
    "address2": "Suite 150",
    "zip_code": "75063",
    "city": "Irving",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}